Department of Medical Imaging and Department of Biostatistics/Joint Department of Medical Imaging, Princess Margaret Cancer Centre, University Health Network, 610 University Ave, Room 3-922, Toronto, ON, Canada.
Radiology. 2013 Jun;267(3):692-700. doi: 10.1148/radiol.13120121. Epub 2013 Feb 15.
To perform semiautomated quantitative analysis of the background enhancement (BE) in a cohort of patients with newly diagnosed breast cancer and to correlate it with mammographic breast density and menstrual cycle.
Informed consent was waived after the research ethics board approved this study. Results of 177 consecutive preoperative breast magnetic resonance (MR) examinations performed from February to December 2009 were reviewed; 147 female patients (median age, 48 years; range, 26-86 years) were included. Ordinal values of BE and breast density were described by two independent readers by using the Breast Imaging Reporting and Data System lexicon. The BE coefficient (BEC) was calculated thus: (SI2 · 100/SI1) - 100, where SI is signal intensity, SI2 is the SI enhancement measured in the largest anteroposterior dimension in the axial plane 1 minute after the contrast agent injection, and SI1is the SI before contrast agent injection. BEC was used for the quantitative analysis of BE. Menstrual cycle status was based on the last menstrual period. The Wilcoxon rank-sum or Kruskal-Wallis test was used to compare quantitative assessment groups. Cohen weighted κ was used to evaluate agreement.
Of 147 patients, 68 (46%) were premenopausal and 79 (54%) were postmenopausal. The quantitative BEC was associated with the menstrual status (BEC in premenopausal women, 31.48 ± 20.68 [standard deviation]; BEC in postmenopausal women, 25.65 ± 16.74; P = .02). The percentage of overall BE was higher when the MR imaging was performed in women in the inadequate phase of the cycle (<35 days, not 7-14 days; mean BEC, 35.7) compared with women in the postmenopausal group (P = .001). Premenopausal women had significantly higher BEC when compared with postmenopausal women (P = .03). There was no significant difference in the percentage of BE between breast density groups.
Premenopausal women with breast cancer, and specifically women in the inadequate phase of the cycle, presented with higher quantitative BE than postmenopausal women. No association was found between BE and breast density.
对一组新诊断乳腺癌患者的背景增强(BE)进行半自动定量分析,并将其与乳腺密度和月经周期相关联。
在研究伦理委员会批准本研究后,获得了患者的知情同意豁免。回顾了 2009 年 2 月至 12 月期间进行的 177 例连续术前乳腺磁共振(MR)检查的结果;纳入了 147 名女性患者(中位年龄 48 岁;范围 26-86 岁)。两名独立的读者使用乳腺影像报告和数据系统词汇表对 BE 和乳腺密度的有序值进行了描述。BE 系数(BEC)的计算方法如下:(SI2·100/SI1)-100,其中 SI 为信号强度,SI2 为轴向平面中注射造影剂后 1 分钟测量的最大前后径的 SI 增强,SI1 为注射造影剂前的 SI。BEC 用于 BE 的定量分析。月经周期状态基于末次月经。采用 Wilcoxon 秩和或 Kruskal-Wallis 检验比较定量评估组。采用 Cohen 加权κ评估一致性。
在 147 名患者中,68 名(46%)为绝经前,79 名(54%)为绝经后。定量 BEC 与月经状态相关(绝经前妇女的 BEC 为 31.48±20.68[标准差];绝经后妇女的 BEC 为 25.65±16.74;P=0.02)。与绝经后组相比,在月经周期不足阶段(<35 天,而非 7-14 天;平均 BEC 为 35.7)进行 MRI 检查的女性中,整体 BE 的百分比更高(P=0.001)。与绝经后妇女相比,绝经前妇女的 BEC 显著升高(P=0.03)。在乳腺密度组之间,BE 的百分比没有显著差异。
患有乳腺癌的绝经前妇女,特别是在月经周期不足阶段的妇女,其定量 BE 高于绝经后妇女。BE 与乳腺密度之间无关联。